Effects of chronic amphetamine or reserpine on self-stimulation responding: Animal model of depression?
- 1 December 1980
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 72 (1) , 9-15
- https://doi.org/10.1007/bf00433801
Abstract
The mood-altering properties of amphetamine (AMPH) in humans (euphoria and depression) have been postulated to be related to the increases and decreases respectively which this drug produces in the sensitivity of the reward system of the brain. The present study further evaluated this relationship by testing the effects of chronic reserpine (RES), another treatment that produces depression in humans, on self-stimulation responding. Separate groups of animals implanted with stimulating electrodes in the medial forebrain bundle were administered daily injections of saline, d-AMPH (5 mg/kg×7days followed by 10 mg/kg×7 days), or RES (0.05 mg/kg×18 days). At treatment termination, both drug groups showed a significant elevation of the reinforcement threshold, with no recovery occurring during 18 subsequent days. Thus, drug-induced depression of self-stimulation responding may serve as an animal model for studying the underlying physiological basis for clinical depression, or at the very least, for drug-induced depression.Keywords
This publication has 20 references indexed in Scilit:
- Response sensitization and depression following long-term amphetamine treatment in a self-stimulation paradigmPsychopharmacology, 1980
- Long-Term Changes in Dopaminergic Innervation of Caudate Nucleus After Continuous Amphetamine AdministrationScience, 1978
- Biphasic effects of amphetamine on striatal dopamine dynamicsEuropean Journal of Pharmacology, 1977
- Behavioral withdrawal following several psychoactive drugsPharmacology Biochemistry and Behavior, 1977
- Amphetamine and the reward system: Evidence for tolerance and post-drug depressionPsychopharmacology, 1976
- Brain Biogenic Amine Depletion and MoodArchives of General Psychiatry, 1974
- Effects of Long-Term Reserpine Treatment on Brain Tyrosine Hydroxylase and Behavioral ActivityScience, 1971
- Behavior “recovery” during chronic reserpine treatment: Effect of dose of reserpinePsychopharmacology, 1969
- DEPRESSION AND ANXIETY OCCURRING DURING RAUWOLFIA THERAPYJAMA, 1955
- Mental Depression in Hypertensive Patients Treated for Long Periods with Large Doses of ReserpineNew England Journal of Medicine, 1954